Trials / Completed
CompletedNCT00448175
Overactive Bladder Innovative Therapy Trial (OrBIT)
Overactive Bladder Innovative Therapy Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Uroplasty, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Urgent PC Neuromodulation System | The Urgent PC Neuromodulation System is a minimally invasive neuromodulation system designed to deliver retrograde access to the sacral nerve through percutaneous electrical stimulation of the tibial nerve. The method of treatment is referred to as Percutaneous Tibial Nerve Stimulation (PTNS). |
| DRUG | Tolterodine |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2007-03-16
- Last updated
- 2013-05-16
- Results posted
- 2013-05-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00448175. Inclusion in this directory is not an endorsement.